FDA Releases Guidance on Data Integrity for In Vivo Bioavailability and Bioequivalence Studies April 11, 2024 AutoBot News 0 The draft guidance provides recommendations for data integrity for clinical and bioanalytical portions of bioavailability and bioequivalence studies submitted with drug applications.